Doctors Recommend A New Drug For The Prevention Of HIV Infection

Doctors Recommend A New Drug For The Prevention Of HIV Infection.
Should individuals in risk of contracting HIV because they have touchy sex take effect a pill to prevent infection, or will the medication encourage them to take even more sexy risks? After years of debate on this question, a new foreign study suggests the medication doesn't lead kith and kin to stop using condoms or have more sex with more people. The research isn't definitive, and it hasn't changed the wits of every expert how much is maxoderm cream in nigeria. But one of the study's co-authors said the findings reinforcing the drug's use as a avenue to prevent infection with HIV, the virus that causes AIDS.

And "People may have more partners or end using condoms, but as well as we can tell, it's not because of taking the drug to preclude HIV infection ," said study co-author Dr Robert Grant, a major investigator with the Gladstone Institute of Virology and Immunology in San Francisco. The medication in ask is called Truvada, which combines the drugs emtricitabine and tenofovir as example. It's normally reach-me-down to play host to people who are infected with HIV, but inspection - in gay and bisexual men and in straight couples with one infected helpmate - have shown that it can lower the risk of infection in ancestors who become exposed to the virus through sex.

However, it does not eliminate the risk of infection. The US Food and Drug Administration approved the narcotic for avoidance purposes in 2012. Few people seem to be taking it for fending purposes, however. Its manufacturer, Gilead, has disclosed that about 1700 consumers are taking the drug for that reason in the United States. In the unheard of study, researchers found that expected rates of HIV and syphilis infection decreased in almost 2500 men and transgender women when they took Truvada.

The scan participants, who all faced enormous risk of HIV infection, were recruited in Peru, Ecuador, South Africa, Brazil, Thailand and the United States. Some of the participants took Truvada while others took an inert placebo. Those who believed they were taking Truvada "were just as justifiable as and Harry else," Grant said, suggesting that they weren't more promising to arrest using condoms or be more unsystematized because they believed they had extra protection against HIV infection.

Grant said the work of the study allows scientists to better understand the choices that participants make. The office is limited, however, because the researchers recruited participants a substitute of waiting for people to come to them. For that reason, it's outrageous to know if people will seek out Truvada to boost new levels of risk by, say, no longer using condoms. There are many skeptics, including the AIDS Healthcare Foundation, who fears that the antidepressant will modestly encourage people to draw riskier decisions in regard to sex.

One of these skeptics is Arleen Leibowitz, a professor emeritus of disreputable policy at the Luskin School of Public Affairs at the University of California, Los Angeles. She said the studio shows that many males and females failed to take Truvada as prescribed and often didn't convey enough to be protected from HIV. That raises the contemplation that some people would take risks because they believe they're protected when they truly aren't.

Leibowitz also said some of the statistics in the study are in dispute because they don't include enough participants. And she said the participants may have lied about their going to bed lives to please the people who interviewed them. "We'll twig a lot when its use becomes more general. But it's doomed to do experiments on the general population".

For the moment the drug may be appropriate for some patients who basic protection from HIV, but doctors should be cautious and coerce sure their patients take the medication. The study is published in the Dec 18, 2013 online print run of the journal PLoS One helpful hints. In other HIV/AIDS news, a imaginative den - also published in PLoS One - reports that 20-year-old men infected with HIV in the United States and Canada can look forward to finish almost as long as the general population and make it, typically, to their dawn 70s.